|
VIAGRA
(SILDENAFIL CITRATE)
DESCRIPTION
SIDE EFFECTS WARNINGS
AND PRECAUTIONS
OVERDOSAGE
BUY VIAGRA
|
Description
Viagra (Sildenafil citrate), an oral therapy for
erectile dysfunction, is the citrate salt of sildenafil,
a selective inhibitor of cyclic guanosine monophosphate
(cGMP)-specific phosphodiesterase type 5 (PDE5).
Viagra (Sildenafil citrate)
is designated chemically as
1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-
5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate.
Viagra (Sildenafil citrate)
is a white to off-white crystalline powder with a solubility
of 3.5 mg/ml in water and a molecular weight of 666.7.
Viagra is formulated as blue, film-coated
rounded-diamond-shaped tablets equivalent to 25 mg, 50 mg
and 100 mg of sildenafil for oral administration. In
addition to the active ingredient, sildenafil citrate, each
tablet contains the following inactive ingredients:
microcrystalline cellulose, anhydrous dibasic calcium
phosphate, croscarmellose sodium, magnesium stearate,
hydroxypropyl methylcellulose, titanium dioxide, lactose,
triacetin, and FD&C blue #2 aluminum lake. |
|
Mechanism of Action
The physiologic mechanism of
erection of the penis involves release of nitric oxide (NO)
in the corpus cavernosum during sexual stimulation. NO then
activates the enzyme guanylate cyclase, which results in
increased levels of cyclic guanosine monophosphate (cGMP),
producing smooth muscle relaxation in the corpus cavernosum
and allowing inflow of blood. Viagra (Sildenafil citrate) has no direct
relaxant effect on isolated human corpus cavernosum, but
enhances the effect of nitric oxide (NO) by inhibiting
phosphodiesterase type 5 (PDE5), which is responsible for
degradation of cGMP in the corpus cavernosum. When sexual
stimulation causes local release of NO, inhibition of PDE5
by Viagra (Sildenafil citrate) causes increased levels of cGMP in the corpus
cavernosum, resulting in smooth muscle relaxation and inflow
of blood to the corpus cavernosum. Sildenafil at recommended
doses has no effect in the absence of sexual stimulation. |
|
Dosage and Administration
For most patients, the
recommended dose is 50 mg taken, as needed, approximately 1
hour before sexual activity. However, sildenafil citrate may
be taken anywhere from 4 hours to 0.5 hour before sexual
activity. Based on effectiveness and toleration, the dose
may be increased to a maximum recommended dose of 100 mg or
decreased to 25 mg. The maximum recommended dosing frequency
is once per day.
The Following Factors are
Associated with Increased Plasma Levels of
Viagra (Sildenafil citrate): Age >65 (40%
increase in AUC), hepatic impairment (e.g.,
cirrhosis, 80%), severe renal impairment (creatinine
clearance <30 ml/min, 100%), and concomitant use of potent
cytochrome P450 3A4 inhibitors (erythromycin, ketoconazole,
itraconazole, 200%, saquinavir 210%). Since higher plasma
levels may increase both the efficacy and incidence of
adverse events, a starting dose of 25 mg should be
considered in these patients. |
|